The latest recommendations and guidelines for the meningitis booster for adolescents

Speaker: George Syrogiannopoulos

Duration: 0:21:16
Learning objectives: At the end of the video, viewers will: (1) Learn that the highest incidence of meningococcal disease occurs in children under 5 years of age, but a second peak occurs in adolescents and higher case fatality rates are generally reported in this age group. (2) Understand that children are being immunized in infancy with the meningococcal serogroup C conjugate vaccine (3) Learn that as children get older the protective antibody titres against meningococcal serogroup C are waning. (4) Adolescents need to receive a booster dose and currently a quadrivalent meningococcal conjugate vaccine (MenACYW), offering coverage against serogroup C, as well against serogroups A, Y and W135, is recommended.



Be the first to comment

Please check your e-mail for a link to activate your account.

get updates